Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9DJX

Ternary complex structure of Cereblon-DDB1 bound to WIZ(ZF7) and the molecular glue WIZ-6

This is a non-PDB format compatible entry.
Summary for 9DJX
Entry DOI10.2210/pdb9djx/pdb
Related9DJT
DescriptorProtein cereblon, DNA damage-binding protein 1, Protein Wiz, ... (7 entities in total)
Functional Keywordscereblon, ligase, molecular glue, degradation
Biological sourceHomo sapiens (human)
More
Total number of polymer chains6
Total formula weight280557.49
Authors
Partridge, J.R.,Ma, X.,Ornelas, E. (deposition date: 2024-09-07, release date: 2024-11-27, Last modification date: 2024-12-11)
Primary citationKerrigan, J.R.,Thomsen, N.M.,Cernijenko, A.,Kochanek, S.E.,Dewhurst, J.,O'Brien, G.,Ware, N.F.,Sanchez, C.C.,Manning, J.R.,Ma, X.,Ornelas, E.,Savage, N.A.,Partridge, J.R.,Patterson, A.W.,Lam, P.,Dales, N.A.,Bonazzi, S.,Borikar, S.,Hinman, A.E.,Ting, P.Y.
Discovery and Optimization of First-in-Class Molecular Glue Degraders of the WIZ Transcription Factor for Fetal Hemoglobin Induction to Treat Sickle Cell Disease.
J.Med.Chem., 67:20682-20694, 2024
Cited by
PubMed Abstract: Sickle cell disease (SCD) is a prevalent, life-threatening condition with few treatment options, attributed to a heritable mutation in β-hemoglobin. Therapeutic induction of fetal hemoglobin (HbF) with small molecules has been pursued as a treatment to ameliorate many disease complications but with limited success. Herein, we report the discovery of , a novel, potent, and selective molecular glue degrader of the transcription factor WIZ that robustly induces HbF expression as a potential treatment for SCD. was optimized from a phenotypic screening hit utilizing insights from X-ray crystallography and computational modeling to improve potency, selectivity and exposure. In an hNBSGW mouse xenograft model, demonstrated robust WIZ degradation and HbF induction. These results highlight the potential of WIZ degraders as a promising therapy for sickle cell disease.
PubMed: 39541509
DOI: 10.1021/acs.jmedchem.4c02251
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.35 Å)
Structure validation

236620

数据于2025-05-28公开中

PDB statisticsPDBj update infoContact PDBjnumon